ATE362378T1 - Verfahren und zusammensetzungen zur bildung einer schützenden immunantwort gegen malaria - Google Patents
Verfahren und zusammensetzungen zur bildung einer schützenden immunantwort gegen malariaInfo
- Publication number
- ATE362378T1 ATE362378T1 AT04716571T AT04716571T ATE362378T1 AT E362378 T1 ATE362378 T1 AT E362378T1 AT 04716571 T AT04716571 T AT 04716571T AT 04716571 T AT04716571 T AT 04716571T AT E362378 T1 ATE362378 T1 AT E362378T1
- Authority
- AT
- Austria
- Prior art keywords
- compositions
- methods
- forming
- immune response
- response against
- Prior art date
Links
- 230000028993 immune response Effects 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 201000004792 malaria Diseases 0.000 title 1
- 230000001681 protective effect Effects 0.000 title 1
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 239000002671 adjuvant Substances 0.000 abstract 1
- 101150078331 ama-1 gene Proteins 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000002502 liposome Substances 0.000 abstract 1
- 244000045947 parasite Species 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
- 239000000277 virosome Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6018—Lipids, e.g. in lipopeptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/379,417 US7198791B2 (en) | 2003-03-03 | 2003-03-03 | Compositions and methods for the generation of protective immune responses against malaria |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE362378T1 true ATE362378T1 (de) | 2007-06-15 |
Family
ID=32926670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04716571T ATE362378T1 (de) | 2003-03-03 | 2004-03-03 | Verfahren und zusammensetzungen zur bildung einer schützenden immunantwort gegen malaria |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7198791B2 (de) |
| EP (1) | EP1599225B1 (de) |
| AT (1) | ATE362378T1 (de) |
| CA (1) | CA2545779A1 (de) |
| DE (1) | DE602004006493T2 (de) |
| DK (1) | DK1599225T3 (de) |
| ES (1) | ES2283992T3 (de) |
| WO (1) | WO2004078099A2 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7198791B2 (en) * | 2003-03-03 | 2007-04-03 | Pluschke, Gerd Et Al. | Compositions and methods for the generation of protective immune responses against malaria |
| EP1669370A1 (de) * | 2004-10-06 | 2006-06-14 | Institut Pasteur | Identifikation von Regionen innerhalb des "Apical Membrane Antigen 1" von Parasiten des Stammes der Apicomplexa, welche als Ziel von Vakzinen und Medikamenten in Frage kommen, die über die Analyse der dreidimensionale Struktur ableitbar sind |
| US20060275777A1 (en) * | 2005-06-03 | 2006-12-07 | Waelti Ernst R | Novel strategies for protein vaccines |
| WO2007099387A1 (en) * | 2006-03-03 | 2007-09-07 | Mymetics Corporation | Virosome-like vesicles comprising gp41-derived antigens |
| EP1938835A1 (de) * | 2006-12-29 | 2008-07-02 | Pevion Biotech AG | Nichtspezifische immunostimulierende Wirkstoffe |
| MX2011007745A (es) | 2009-02-06 | 2011-12-08 | Mymetics Corp | Division de gp41. |
| EP2393510A1 (de) | 2009-02-06 | 2011-12-14 | Mymetics Corporation | Neue gp41-antigene |
| EP2451477A4 (de) * | 2009-11-13 | 2013-08-14 | Us Navy | Auf plasmodium falciparum-hla der klasse i beschränkte t-zellen-epitope |
| CN102781958B (zh) * | 2009-12-05 | 2017-07-11 | 马尔瓦有限责任公司 | 基于顶复虫Ferlin、Ferlin样蛋白和其它含有C2结构域的蛋白的疟疾疫苗 |
| WO2011128720A1 (en) | 2010-04-14 | 2011-10-20 | Mymetics Corporation | Trans-activator of transcription protein |
| EP3081575A1 (de) | 2015-04-12 | 2016-10-19 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Anti-plasmodium-parasiten-antikörper |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0372019B1 (de) * | 1988-02-12 | 1995-05-31 | Saramane Pty. Ltd. | RHOPTRY-MEMBRAN-ANTIGEN VON $i(PLASMODIUM FALCIPARUM) |
| JPH06505397A (ja) | 1991-03-20 | 1994-06-23 | ヴァイロジェネティクス コーポレイション | マラリア組換体ポックスウイルス |
| AU2001277840A1 (en) * | 2000-03-07 | 2002-03-04 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
| WO2002052014A2 (en) * | 2000-12-22 | 2002-07-04 | Stichting Biomedical Primate Research Centre | Efficient expression of plasmodium apical membrane antigen 1 in yeast cells |
| CN1176945C (zh) * | 2001-02-01 | 2004-11-24 | 中国人民解放军第二军医大学 | 疟原虫融合抗原及其制法和用途 |
| US7029685B2 (en) * | 2001-03-26 | 2006-04-18 | The United States Of America As Represented By The Secretary Of The Army | Plasmodium falciparum AMA-1 protein and uses thereof |
| CA2441952C (en) * | 2001-03-26 | 2010-06-01 | Walter Reed Army Institute Of Research | Plasmodium falciparum ama-1 protein and uses thereof |
| US6704957B2 (en) * | 2002-07-31 | 2004-03-16 | Steven L. Rhodes | Patient support pad for medical imaging equipment |
| US7198791B2 (en) * | 2003-03-03 | 2007-04-03 | Pluschke, Gerd Et Al. | Compositions and methods for the generation of protective immune responses against malaria |
-
2003
- 2003-03-03 US US10/379,417 patent/US7198791B2/en not_active Expired - Lifetime
-
2004
- 2004-03-03 CA CA002545779A patent/CA2545779A1/en not_active Abandoned
- 2004-03-03 EP EP04716571A patent/EP1599225B1/de not_active Expired - Lifetime
- 2004-03-03 ES ES04716571T patent/ES2283992T3/es not_active Expired - Lifetime
- 2004-03-03 DE DE602004006493T patent/DE602004006493T2/de not_active Expired - Lifetime
- 2004-03-03 AT AT04716571T patent/ATE362378T1/de active
- 2004-03-03 WO PCT/EP2004/002126 patent/WO2004078099A2/en active IP Right Grant
- 2004-03-03 DK DK04716571T patent/DK1599225T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004078099A2 (en) | 2004-09-16 |
| EP1599225A2 (de) | 2005-11-30 |
| DK1599225T3 (da) | 2007-09-24 |
| US20040175392A1 (en) | 2004-09-09 |
| ES2283992T3 (es) | 2007-11-01 |
| DE602004006493D1 (de) | 2007-06-28 |
| WO2004078099A3 (en) | 2004-10-28 |
| AU2004216833A1 (en) | 2004-09-16 |
| CA2545779A1 (en) | 2004-09-16 |
| DE602004006493T2 (de) | 2007-09-13 |
| EP1599225B1 (de) | 2007-05-16 |
| US7198791B2 (en) | 2007-04-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE318899T1 (de) | Fusionsproteine, die stressproteine beinhalten, zum hervorrufen einer immunantwort | |
| ATE362378T1 (de) | Verfahren und zusammensetzungen zur bildung einer schützenden immunantwort gegen malaria | |
| CY1113546T1 (el) | Μικρορευστοποιημενα γαλακτωματα ελαιου σε νερο και συνθεσεις εμβολιων | |
| NO20023829D0 (no) | Proteosom influensavaksine | |
| DE122011100054I1 (de) | Influenza vakzinzusammensetzungen zur intradermaler verabreichung. | |
| WO2007016185A3 (en) | Mono-and bi-functional antibody conjugates as effective adjuvants of protein vaccination | |
| WO2006036550A3 (en) | Listeria-based and llo-based vaccines | |
| WO2018193063A3 (en) | NEW VACCINES AGAINST MALARIA AND ANTIBODIES BINDING PLASMODIUM SPOROZOIDS | |
| DE60117164D1 (de) | Impfstoffe mit erhöhter immunantwort und verfahren zur deren herstellung | |
| IS4518A (is) | Nýtt lyfjaform fyrir bóluefni | |
| UA93508C2 (en) | Anti-malaria vaccine | |
| WO2008054535A3 (en) | Novel influenza m2 vaccines | |
| Hirunpetcharat et al. | CpG oligodeoxynucleotide enhances immunity against blood-stage malaria infection in mice parenterally immunized with a yeast-expressed 19 kDa carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein-1 (MSP119) formulated in oil-based Montanides | |
| WO2005007673A3 (en) | Immunogenic peptides | |
| DE69520943D1 (de) | Malariapeptide | |
| EP2899203A3 (de) | Leishmania impfstoff unter verwendung von sandmücke speichelimmunogen | |
| DE69836976D1 (de) | Neospora impstoff | |
| WO2013171661A3 (en) | Adjuvant formulations and methods | |
| TNSN08184A1 (en) | Chimeric antigens and vaccines | |
| WO2005049647A3 (en) | Compositions comprising melittin-derved peptides and methods for the potentiation of immune responses against target antigens | |
| WO2007020520A3 (en) | Antigenic peptides and their use | |
| WO2007006052A3 (en) | Malaria msp-1 c-terminal enhanced subunit vaccine | |
| ATE353226T1 (de) | Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form | |
| WO2006126029A3 (en) | Malaria vaccines | |
| AR027738A1 (es) | Composicion coadyuvante, composiciones de vacunas que incluyen dicha composicion coadyuvante; procedimiento de induccion de inmunorespuestas antigenicas enmamiferos y procedimiento de tratamiento donde se aplican dichas vacunas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1599225 Country of ref document: EP |